Skip to main content
. 2015 Sep 2;6(29):27037–27048. doi: 10.18632/oncotarget.4815

Figure 7. A scheme showing the potential role of c-kit signaling in the development of CRMAC.

Figure 7

SCF triggered c-kit signaling might increase cyclin D1 and decrease p53 through activating AKT pathway, thus enhance tumor cell proliferation. Furthermore, stimulated c-kit could increase ETV4 through activating MEK/ERK pathway, consequently confer a stronger capacity of tumor invasion.